MedWellAI is a small holding company that recently pivoted to AI-driven healthcare distribution. Its core operating business, MedWell USA, is a B2B e-commerce platform that connects healthcare providers — including wellness clinics, med spas, and corporate wellness facilities — with pharmaceutical suppliers of GLP-1 medications used for weight loss and diabetes management. MedWell USA earns commissions by facilitating orders between providers and suppliers, without taking ownership of inventory, which limits capital requirements. The platform includes an AI-powered ordering system with real-time inventory tracking. The company previously operated a Bitcoin mining business at a hosted facility in Texas, which was shut down in mid-2024 and classified as discontinued operations. It also briefly acquired a 51% stake in Healthy Lifestyle USA, a direct-to-consumer health products business, but abandoned that business within a year due to regulatory hurdles. MedWellAI has one full-time employee — its sole officer and director — and trades on the OTCQB marketplace. With Bitcoin mining discontinued, the company acknowledges it may need to raise additional capital to fund operations.